期刊文献+

四种益生元聚糖对高脂血症仓鼠血脂的影响 被引量:2

Hypolipidemic Effects of Four Species of Prebiotics in Hyperlipidemic Hamsters
下载PDF
导出
摘要 探讨聚葡萄糖,聚木糖,菊粉,阿拉伯半乳聚糖四种聚糖类益生元对高血脂仓鼠的血脂调节作用。采用高脂饲料喂饲健康成年雄性仓鼠,以诱发高脂血症,同时分别喂饲添加0.5%的聚葡萄糖,聚木糖,菊粉,阿拉伯半乳聚糖(AG)的高脂饲料,观察四种益生元聚糖对仓鼠血清胆固醇(TC)、甘油三酯(TG)和高密度脂蛋白胆固醇(HDL-C)含量的影响。结果表明:1)四种益生元聚糖均能显著性降低进食高脂饲料仓鼠的空腹血清总胆固醇(TC)和非高密度脂蛋白胆固醇(Non-HDL-C)含量;2)除阿拉伯半乳聚糖外,其它三种益生元聚糖均能显著性地降低喂饲6周仓鼠肝脏组织TC含量,四种益生元聚糖均能显著性降低肝脏TG水平。因此,四种益生元聚糖具有较显著的调节血脂的作用。 To explore the effects of several prebiotics that polydextrose, polyxylose, inulin, arabinogalactan (AG) on the level of blood lipid in hamsters. The animal model of hyperlipidemia in healthy male hamsters was established by feeding diets riehed in high cholesterol, in the meantime the four prebiotics were given at a level of 5 % in the diets. Observe the effects of four prebiotics on the total cholesterol (TC), triglycerides (TG) and high density lipoprotein cholesterol (HDL-C) in serm and liver of hamsters. Results showed: 1 ) the prebiotics could reduce the levels of serum TC and Non-HDL-C of hamsters fed on a lipid rich diet obviously, while the level of TG and HDL-C in serum did not changed in all groups during the experiment. 2) the prebiotics could reduce the total cholesterol levels in liver tissue of hamsters obviously except for arabinogalactan. And all prebiotics could decrease triglyceride in liver tissue obviously. Therefore the four prebiotics could regulate the lipid of blood observably.
出处 《食品研究与开发》 CAS 北大核心 2013年第8期93-96,109,共5页 Food Research and Development
基金 天津市高等学校科技发展基金计划项目(20100609)
关键词 益生元 聚葡萄糖 聚木糖 菊粉 阿拉伯半乳聚糖 降血脂 prebiotics polydextrose polyxylose inulin arabinogalactan hypolipidemic
  • 相关文献

参考文献15

  • 1Gibson G R, Roberfroid M B. Dietary modulation of the human colonic microbiota: introducing the concept of prebiotics[J]. Journal of nutrition, 1995,125(6): 1401-1412.
  • 2朱俊玲,卢智.功能性低聚糖的研究进展及其应用现状[J].食品研究与开发,2003,24(3):72-75. 被引量:23
  • 3Yanahira S, Morita M, Aoe S, et al. Effect of Lactitololigosaccharides on the intestinal microflora in rats[J]. Nutr Sci Vitaminol,1995,41(1): 83-94.
  • 4刘迎利,李建科.高血脂的病因及治疗[J].现代医药卫生,2004,20(7):522-523. 被引量:26
  • 5任勇,褚(摘).血脂异常 健康杀手幕后主谋[J].健康文摘,2006(12):4-5. 被引量:5
  • 6Rifkind B M, Lenfant C. Cholesterol lowering and the reduction of coronary heart disease risk[J]. JAMA, 1986, 256(20): 2872-2873.
  • 7Blankenhorn D H, Nessim, S A, Johnson R L, et al. Beneficial effectsof combined colestipol-niacin therapy on coronary atherosclerosis and coronary venous bypass grafts[J]. JAMA, 1987, 257(23): 3233- 3240.
  • 8Brown G, Albers J J, Lloyd D, et al. Regression of coronary artery disease as a result of intensive lipid-lowering therapy in men with high levels of apolipoprotein[J]. B N Engl J Med,1990,323(19): 1289-1298.
  • 9Shepherd J, Cobbe S M, Ford I Isles, et al. Prevention of coronary heart disease with pravastain in men with hypocholesterolemia[J]. N Engl J Med,1995,333(20):1301-1307.
  • 10Watts G F, Lewis B, Brunt J N, et al. Effects on coronary artery dis- ease of lipid- lowering diet plus cholestyamine, in the St Thomas' Atherosclerosis Regression Study (Stars)[J].Lancet,1992,339(8793):563-569.

二级参考文献104

共引文献143

同被引文献32

引证文献2

二级引证文献25

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部